期刊
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
卷 104, 期 19, 页码 8105-8116出版社
SPRINGER
DOI: 10.1007/s00253-020-10846-y
关键词
Visceral and cutaneous leishmaniasis; Conventional diagnosis; Serological diagnosis; Flow cytometry diagnosis; Diagnosis by biosensors
资金
- Brazilian agency CNPq [435224/2018-2]
- Brazilian agency FAPEMIG [APQ-03505-13, APQ-01373-14, APQ 02577-18, APQ-02556-18]
- Brazilian agency CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brasil (CAPES)) [001]
- Brazilian agency Universidade Federal de Ouro Preto - UFOP
- CAPES
- CNPq
Leishmaniasis is a set of complex and multifaceted syndromes, with different clinical manifestations, caused by different species of the genusLeishmaniaspp. that can be characterized by at least four syndromes: visceral leishmaniasis (VL, also known as kala-azar), post-kala-azar dermal leishmaniasis (PKDL), cutaneous leishmaniasis (CL), and mucocutaneous leishmaniasis (MCL). Among the most serious clinical forms, VL stands out, which causes the death of around 59,000 people annually. Fast and accurate diagnosis in VL is essential to reduce the disease's morbidity and mortality. There are a large number of diagnostic tests for leishmaniasis, however they do cross-react with other protozoa and their sensitivity changes according to the clinical form of the disease. Thus, it is essential and necessary to provide a diagnosis that is sufficiently sensitive to detect asymptomatic infected individuals and specific to discriminate individuals with other infectious and parasitic diseases, thus enabling more accurate diagnostic tools than those currently used. In this context, the aim of this review is to summarize the conventional diagnostic tools and point out the new advances and strategies on visceral and cutaneous leishmaniasis diagnosis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据